Thu, Aug 20 03:07 AM

Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis - Slideshow

Seeking Alpha•Thu, Aug 20, 2026, 01:31 AM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Seeking Alpha](https://seekingalpha.com/article/4938513-tvardi-therapeutics-inc-tvrd-discusses-ttiminus-109-development-program-and-data-in?source=feed_all_articles)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Seeking Alpha ↗

#finance #tvardi #therapeutics #inc #tvrd #discusses #tti #development #program

More Headlines

FinanceCNBC• 7m ago

Hyundai's new flagship vehicle is a large luxury Genesis EV

The GV90 features a new design direction for Genesis and expands the Hyundai brand's lineup to seven vehicles in the U. S.

FinanceSeeking Alpha• 16m ago

NZX Limited (NZSTY) Q2 2026 Earnings Call Transcript

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 20m ago

Gold holds near 2-month high as Treasury buybacks push yields, dollar lower

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 21m ago

Artiva Biotherapeutics CMO sells $5,148 in stock

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 21m ago

Netlist EVP and CFO Gail Sasaki sells shares worth $690,660.

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 23m ago

Bega Cheese FY2026 slides: ROFE target hit 2 years early

Developing story — details emerging. Check the source link for the latest updates.